Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001492422-26-000017
Filing Date
2026-01-09
Accepted
2026-01-09 18:48:43
Documents
1
Period of Report
2026-01-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7418
  Complete submission text file 0001492422-26-000017.txt   8811
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address
Watson David O. (Reporting) CIK: 0001657719 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 26524312